Table 2.

Myopia progression during three years of the study SE: spherical equivalent, SV: single-vision spectacle lenses. A0.01: 0.01% atropine for two years of treatment. A0.01% + DFCL: contact.

	Myopia Progression SE (D)
Groups	Year 1	Year 2	Year 3
SV	1.19 ± 0.43	1.25 ± 0.52	1.13 ± 0.36
A0.01%	0.44 ± 0.21	0.51 ± 0.39	0.24 ± 0.35
A0.01% + DFCL	0.35 ± 0.26	0.44 ± 0.40	0.18 ± 0.34
SV vs. A0.01%	p < 0.001	p < 0.001	p < 0.001
SV vs. A0.01% + DFCL	p < 0.001	p < 0.001	p < 0.001
A0.01% vs. A0.01% + DFCL	p > 0.05	p > 0.05	p > 0.05